Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Gastroenterology
Study Phase : Approved
Sponsor : Biocodex
Deal Size : Undisclosed
Deal Type : Acquisition
Details : The acquisition is a key part of the Group’s international growth strategy and will enable Biocodex to consolidate its presence in the digestive health and women’s health segments of the US market.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
November 17, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Gastroenterology
Highest Development Status : Approved
Sponsor : Biocodex
Deal Size : Undisclosed
Deal Type : Acquisition
LOOKING FOR A SUPPLIER?